Antipodes Partners’s Walgreens Boots Alliance WBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-3,307,927
Closed -$114M – 80
2023
Q1
$114M Buy
3,307,927
+1,118,671
+51% +$39.7M 3.96% 9
2022
Q4
$81.8M Buy
2,189,256
+326,273
+18% +$12.3M 2.93% 13
2022
Q3
$58.5M Sell
1,862,983
-275,580
-13% -$10.2M 2.35% 18
2022
Q2
$81.1M Sell
2,138,563
-221,440
-9% -$9.52M 3.38% 13
2022
Q1
$106M Buy
2,360,003
+118,885
+5% +$5.85M 3.75% 13
2021
Q4
$117M Sell
2,241,118
-425,243
-16% -$20.6M 4.2% 9
2021
Q3
$125M Buy
2,666,361
+78,094
+3% +$3.77M 4.29% 9
2021
Q2
$136M Buy
2,588,267
+393,764
+18% +$21.2M 4.91% 8
2021
Q1
$120M Buy
2,194,503
+1,059,285
+93% +$52.4M 4.88% 7
2020
Q4
$45.3M Buy
1,135,218
+912,018
+409% +$35.3M 1.97% 23
2020
Q3
$8.02M Buy
+223,200
New +$8.73M 0.37% 31

Other funds holding WBA

Antipodes Partners's WBA Position: Q2 2023 in Review

Antipodes Partners sold out of Walgreens Boots Alliance (WBA) in Q2 2023, closing a stake of 3,307,927 shares — an estimated $114M sold.

Antipodes Partners first reported a position in WBA in Q3 2020 and held it in 11 quarters. The position peaked at $136M in Q2 2021. 1,147 funds tracked by Wall St. Rank hold WBA as of Q2 2023.

  • Antipodes Partners reported no remaining Walgreens Boots Alliance position as of Q2 2023 after selling out during the quarter.
  • Antipodes Partners sold 3,307,927 Walgreens Boots Alliance shares in Q2 2023, an estimated $114M.
  • Antipodes Partners first reported a position in Walgreens Boots Alliance in Q3 2020 and held it in 11 quarters.
  • Antipodes Partners's Walgreens Boots Alliance position peaked at $136M in Q2 2021.
  • 1,147 funds tracked by Wall St. Rank held Walgreens Boots Alliance as of Q2 2023.

Based on Antipodes Partners's 13F filing for Q2 2023, filed 25 Jul 2023.